Inovio Pharmaceuticals, Inc. (INO) financial statements (2021 and earlier)

Company profile

Business Address 6769 MESA RIDGE RD.
SAN DIEGO, CA 92121
State of Incorp. DE
Fiscal Year End December 31
SIC 3841 - Surgical and Medical Instruments and Apparatus (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)
Annual | Quarterly

12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments, including:90811271051639453
Cash and cash equivalents22242419584134
Short-term investments6758104861055319
Other undisclosed cash, cash equivalents, and short-term investments(0)(0)     
Receivables24617733
Other undisclosed current assets3343233
Total current assets:94881381251729959
Noncurrent Assets
Operating lease, right-of-use asset14✕✕✕✕✕✕
Property, plant and equipment1316189753
Long-term investments and receivables 9916151310
Long-term investments 9916151310
Intangible assets, net (including goodwill)14151718141516
Goodwill11111111101010
Intangible assets, net (excluding goodwill)4568456
Other noncurrent assets3332100
Other undisclosed noncurrent assets60245 0
Total noncurrent assets:50434949423330
TOTAL ASSETS:14413118717421413288
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:182323201365
Accrued liabilities 696321
Employee-related liabilities998743 
Other undisclosed accounts payable and accrued liabilities9877614
Deferred revenue0✕✕✕✕✕✕
Debt2      
Deferred rent credit 1✕✕✕✕✕
Due to related parties1111001
Deferred revenue and credits✕✕2151432
Contract with customer, liability✕0✕✕✕✕✕
Other undisclosed current liabilities1110984421
Total current liabilities:32353544311429
Noncurrent Liabilities
Long-term debt and lease obligation20      
Operating lease, liability20✕✕✕✕✕✕
Liabilities, other than long-term debt9996655
Deferred revenue and credits✕✕96655
Deferred revenue0✕✕✕✕✕✕
Contract with customer, liability✕0✕✕✕✕✕
Deferred rent credit 9✕✕✕✕✕
Deferred tax liabilities, net✕  0010
Deferred income tax liabilities0✕✕✕✕✕✕
Other liabilities00     
Derivative instruments and hedges, liabilities9      
Other undisclosed noncurrent liabilities77000111
Total noncurrent liabilities:107997666
Total liabilities:139444550382035
Stockholders' equity
Stockholders' equity attributable to parent, including:38714212317611152
Common stock0000000
Additional paid in capital743708666557534443348
Accumulated other comprehensive income (loss)0(1)(0)13(0)(0)
Accumulated deficit(740)(620)(523)(435)(361)(332)(296)
Warrants and rights outstanding     220
Other undisclosed stockholders' equity attributable to parent     (2)(20)
Stockholders' equity attributable to noncontrolling interest2000000
Total stockholders' equity:58714212317611253
TOTAL LIABILITIES AND EQUITY:14413118717421413288

Income statement (P&L) ($ in millions)
Annual | Quarterly

12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
Revenue, net✕✕4235411013
Net investment income3      
Gross profit:4304235411013
Operating expenses(115)(125)(126)(112)(75)(50)(33)
Operating loss:(111)(94)(84)(76)(34)(39)(20)
Nonoperating income (expense)0    (0)(0)
Investment income, nonoperating     (0)(0)
Other nonoperating income0      
Interest and debt expense(8)      
Loss from continuing operations before equity method investments, income taxes:(119)(94)(84)(76)(34)(40)(20)
Other undisclosed income (loss) from continuing operations before income taxes(2)(1)(5)23  
Loss from continuing operations before income taxes:(121)(95)(88)(74)(31)(40)(20)
Income tax expense (benefit)0(2)  2(0)(0)
Loss before gain (loss) on sale of properties:(121)(97)(88)(74)(29)(40)(20)
Other undisclosed net income (loss)     3(46)
Net loss:(121)(97)(88)(74)(29)(36)(66)
Net income (loss) attributable to noncontrolling interest1   (0)00
Net loss attributable to parent:(119)(97)(88)(74)(29)(36)(66)
Other undisclosed net loss available to common stockholders, basic  (1) (1)(2) 
Net loss available to common stockholders, diluted:(119)(97)(89)(74)(30)(38)(66)

Comprehensive Income ($ in millions)
Annual | Quarterly

12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
Net loss:(121)(97)(88)(74)(29)(36)(66)
Other comprehensive income0      
Other undisclosed comprehensive income (loss)1(0)(1)(1)3(0)(0)
Comprehensive loss:(120)(97)(90)(75)(26)(36)(66)
Comprehensive income (loss), net of tax, attributable to noncontrolling interest1   (0)0(0)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent    0(0) 
Comprehensive loss, net of tax, attributable to parent:(118)(97)(90)(75)(26)(36)(66)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: